Project Grant HT94252410301
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$666K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40526, USA
Similar Awards
This federal Project Grant award, valued at $860,998.00 and issued by the Defense Health Agency, supports research under the Military Medical Research and Development (CFDA 12.420) program. The grant funds the University of California, San Francisco to conduct advanced research on the "Neurophysiology of Post-Traumatic Epilepsy: Unraveling Epileptogenesis Signals Biomarkers" over a 3-year period from April 1, 2025 to March 31, 2028. This research aims to transform healthcare for...
The University of Cincinnati Sponsored Research Services Division was awarded an $817,296 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research on spreading depolarizations as a predictive biomarker of post-traumatic epilepsy from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research...
This federal Project Grant award, valued at $707,436.00 and provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research at the Albert Einstein College of Medicine to investigate biomarker signatures related to post-traumatic epileptogenesis (PTEGENESIS) and treatments. The project has an award date of May 1, 2025 and an ultimate completion date of April 30, 2027. Additionally, the award includes a sub-grant...
This federal Project Grant award of $1,072,500.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to reduce post-traumatic epilepsy by blocking MIAT signaling in parvalbumin-positive inhibitory GABAergic interneurons. The award, with a performance period from April 1, 2025 to March 31, 2028, is granted to the Trustees of Tufts College, doing business as Tufts University School of Medicine, a prominent research...
This federal Project Grant award for $954,307.97, issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Kentucky Research Foundation to repurpose the drug ebselen for treating traumatic brain injury (TBI)-induced pathological tau protein accumulation in tauopathies and Alzheimer's disease. The research aims to advance understanding of how ebselen can activate the protein PPAR-sigma receptor to...
The Department of the Army Medical Command awarded a $3,099,990 project grant to the Western Institute For Veterans Research under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the MILITARY INJURIES - UNDERSTANDING POST-TRAUMATIC EPILEPSY (MINUTE): BIOINFORMATICS WITH BIG DATA TO EXAMINE MULTIMODAL PTE BIOMARKERS project from September 30, 2021 through September 29, 2025. The project aims to utilize bioinformatics and big data approaches to examine...
The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded Encephalogix, Inc. a $459,994 Project Grant to support epilepsy research. The award, effective from Sep 1, 2024 to Aug 31, 2025, will fund the company's "Epilepsy Research Program Idea Development Award" to explore innovative approaches to the prevention, diagnosis, treatment, and management of epilepsy, a condition relevant to military...
This $210,147 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the Baltimore Research & Education Foundation Inc. in increasing epilepsy self-management access for veterans through a partnered hub and spoke model. The award period runs from April 1, 2025 to March 31, 2028. The foundation, a non-profit organization and research institution, will leverage its expertise in biomedical research and healthcare...
This Project Grant from the Defense Health Agency provides $745,381 to Virginia Commonwealth University from June 1, 2023 through May 31, 2026 to support research on "POST-TRAUMATIC EPILEPTOGENESIS: ROLE OF NEOCORTICAL-HIPPOCAMPAL INTERACTIONS" under the Military Medical Research and Development program (CFDA 12.420). VCU will conduct this research to advance the program's goals of transforming military and public healthcare through innovative biomedical research solutions. Subawards...
The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to...